These breakthrough gene therapies cost millions of dollars. Is a mortgage model the secret to paying for them?

Get the Full StoryBanks and private equity are the solutions

In recent years, the FDA has approved dozens of gene and cell therapies that can potentially cure rare diseases like sickle cell disease and spinal muscular atrophy. But many patients still can t access these treatments because insurers have refused to cover them.

Share: